-

BLUEBIRD BIO INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of bluebird bio, Inc. - BLUE

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into bluebird bio, Inc. (NasdaqGS: BLUE).

In May 2020, the Company announced its plans to submit an application to the U.S. Food and Drug Administration (“FDA”) for its product, LentiGlobin, in the second half of 2021. Then, on November 4, 2020, the Company disclosed that, due to the FDA requiring the Company to provide additional data, it was adjusting the timing of its submission to late 2022.

Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws, which remains ongoing.

KSF’s investigation is focusing on whether bluebird’s officers and/or directors breached their fiduciary duties to bluebird’s shareholders or otherwise violated state or federal laws.

If you have information that would assist KSF in its investigation, or have been a long-term holder of bluebird shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-blue/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

Kahn Swick & Foti, LLC

NASDAQ:BLUE

Release Versions

Contacts

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850

More News From Kahn Swick & Foti, LLC

York Space 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against York Space Systems, Inc. - YSS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 30, 2026 to file lead plaintiff applications in a securities class action lawsuit against York Space Systems, Inc. (“York” or the “Company”) (NYSE: YSS), if they purchased or otherwise acquired (a) York Space Systems common stock pursuant and/or traceable to the registration statement and prospec...

Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Surgery Partners, Inc. (NasdaqGS: SGRY) to HealthSpan Partners. Under the terms of the proposed transaction, shareholders of Surgery Partners will receive $23.50 in cash for each share of Surgery Partners that they own. KSF is seeking to determine whether this consideration and the process that led...

Range Resources Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Range Resources Corporation - RRC

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Range Resources Corporation (NYSE: RRC) to EQT Corporation (NYSE: EQT). Under the terms of the proposed transaction, shareholders of Range will receive 0.987 shares of EQT common stock for each share of Range that they own. Upon completion of the proposed transaction, Range shareholders are expected...
Back to Newsroom